Human Immunodeficiency Virus HIV near Passaic, NJ

Biography: Dr. Gordon is the Medical Director of the Comprehensive Health Program (CHP) at NewYork-Presbyterian Hospital's Columbia campus and a Professor of Medicine at Columbia University's School of Physicians and Surgeons. Dr. Gordon is a practicing HIV/HCV Specialist and Primary Care Provider within the Designated AIDS Center at NewYork-Presbyterian, a clinical investigator within the Columbia Collaborative HIV/AIDS Clinical Trials Unit, and a clinical investigator at Columbia University's HIV Center for Clinical and Behavioral Science. He is the former Chair of the New York State AIDS Institute Quality of Care Advisory Committee and currently serves on the Clinical and Research Committees of Healthix, a regional health information exchange (RHIO) based in NYC. Dr. Gordon's research interests and contributions have focused upon healthcare delivery systems evaluation, consumer health information technology, bioinformatics, HIV and Hepatitis C care and prevention. Recent work has focused upon understanding and improving HIV and HCV care and prevention services through IT enabled institutional care cascades, EHR enhanced HIV risk assessment, and health information exchange event notification for people living with HIV and HCV who are lost to care. He has authored or co-authored over 30 scientific articles on topics ranging from HIV prevention, workforce development, HIV testing, therapeutics, and bioinformatics. He currently is the Principle Investigator on a number of CDC, NIH, HRSA, and NYC DOHMH HIV research and service delivery grants.

Biography: Marcus Pereira, MD, is an Associate Professor of Medicine at CUMC and the Director of Clinical Services in the Division of Infectious Diseases. In addition, he is the Medical Director of the Transplant Infectious Diseases Program, where he oversees the development of infection prophylaxis and treatment protocols for immunocompromised patients. His areas of interest include the management of multi-drug resistant bacterial and fungal infections, as well as drug resistant CMV infections and more recently the impact of COVID-19 in transplant recipients. He has also collaborated in important multi-center studies as well as the 2025 International CMV Guidelines, sponsored by the Transplantation Society. Dr. Pereira is an active member in national societies such as the American Society of Transplantation and Infectious Disease Society of America, and is an Associate Editor for the American Journal of Transplantation.